Financials The Ensign Group, Inc.

Equities

ENSG

US29358P1012

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 10:22:25 2024-05-08 am EDT 5-day change 1st Jan Change
117.8 USD -0.12% Intraday chart for The Ensign Group, Inc. -1.67% +4.68%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,421 3,912 4,593 5,203 6,283 6,660 - -
Enterprise Value (EV) 1 2,421 3,912 4,593 5,203 6,283 6,660 6,660 6,660
P/E ratio 23 x 23.8 x 24.5 x 24 x 30.7 x 23.9 x 21.8 x 19.9 x
Yield 0.42% - 0.25% 0.24% - - - -
Capitalization / Revenue 1.06 x 1.63 x 1.75 x 1.72 x 1.68 x 1.6 x 1.47 x 1.32 x
EV / Revenue 1.06 x 1.63 x 1.75 x 1.72 x 1.68 x 1.6 x 1.47 x 1.32 x
EV / EBITDA 10.4 x 13.4 x 13.6 x 13.6 x 15 x 14.1 x 12.7 x 11.4 x
EV / FCF 20.1 x - 22.3 x 28.1 x - 25.8 x 21.8 x 19.5 x
FCF Yield 4.99% - 4.49% 3.55% - 3.87% 4.58% 5.12%
Price to Book 3.71 x - 4.54 x 4.22 x - - - -
Nbr of stocks (in thousands) 53,353 53,648 54,705 54,998 55,994 56,465 - -
Reference price 2 45.37 72.92 83.96 94.61 112.2 118.0 118.0 118.0
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,286 2,403 2,627 3,025 3,729 4,154 4,535 5,051
EBITDA 1 232.4 292.8 336.6 383.6 419.5 473.7 525.5 583.6
EBIT 1 144.6 238.2 280.6 321.2 347.1 380.2 430.8 472
Operating Margin 6.33% 9.91% 10.68% 10.62% 9.31% 9.15% 9.5% 9.34%
Earnings before Tax (EBT) 1 116.2 217.6 258 289.1 272.8 398.5 447.8 501.7
Net income 1 110.5 170.5 194.7 224.7 209.4 302.3 339.5 380.4
Net margin 4.84% 7.1% 7.41% 7.43% 5.61% 7.28% 7.49% 7.53%
EPS 2 1.970 3.060 3.420 3.950 3.650 4.940 5.420 5.940
Free Cash Flow 1 120.7 - 206.1 185 - 258 305 341
FCF margin 5.28% - 7.85% 6.11% - 6.21% 6.73% 6.75%
FCF Conversion (EBITDA) 51.92% - 61.25% 48.22% - 54.47% 58.04% 58.43%
FCF Conversion (Net income) 109.18% - 105.9% 82.32% - 85.35% 89.84% 89.65%
Dividend per Share 0.1925 - 0.2125 0.2225 - - - -
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 693.1 713.4 732.5 770 809.5 886.8 921.3 940.8 980.4 1,010 1,022 1,042 1,077 1,119 1,135
EBITDA 1 88.43 92.73 96.1 96.59 98.16 99.78 102.8 108 108.9 112.8 115.4 119.9 125.6 127.2 126.7
EBIT 1 73.83 78.05 81.24 80.65 81.28 82.67 85.2 89.6 89.64 93.13 92.3 96.52 101.8 100.5 100.8
Operating Margin 10.65% 10.94% 11.09% 10.47% 10.04% 9.32% 9.25% 9.52% 9.14% 9.22% 9.03% 9.26% 9.45% 8.99% 8.89%
Earnings before Tax (EBT) 1 66.02 66.23 72.96 72.46 77.45 78.38 81.05 82.04 31.28 89.6 94.88 99.38 109.2 108.5 106.7
Net income 1 48.74 50.34 57.69 56.18 60.47 59.85 63.99 63.86 21.69 68.84 71.99 75.31 82.86 82.28 80.96
Net margin 7.03% 7.06% 7.88% 7.3% 7.47% 6.75% 6.95% 6.79% 2.21% 6.81% 7.05% 7.23% 7.69% 7.36% 7.14%
EPS 2 0.8600 0.8900 1.010 0.9900 1.060 1.050 1.120 1.110 0.3800 1.190 1.180 1.220 1.350 1.300 1.300
Dividend per Share 0.0550 0.0550 0.0550 0.0550 0.0575 0.0575 - 0.0575 - - - - - - -
Announcement Date 2/9/22 4/28/22 8/1/22 10/26/22 2/2/23 4/26/23 7/27/23 10/25/23 2/1/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 121 - 206 185 - 258 305 341
ROE (net income / shareholders' equity) 17.6% 23.1% 21.2% 19.8% 15.3% 19.1% - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 12.20 - 18.50 22.40 - - - -
Cash Flow per Share 3.430 - 4.840 4.790 - - - -
Capex 71.5 - 69.6 87.5 - - - -
Capex / Sales 3.13% - 2.65% 2.89% - - - -
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
118 USD
Average target price
134.5 USD
Spread / Average Target
+14.03%
Consensus
  1. Stock Market
  2. Equities
  3. ENSG Stock
  4. Financials The Ensign Group, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW